Tiapride
N05L - N05L
ATC N05AL03
Small molecule
Natural product
JFDA label: TIAPRIDAL TAB
Mechanism of Action
Antagonist of D(3) dopamine receptor — Dopamine D3 receptor antagonist; Antagonist of D(2) dopamine receptor — Dopamine D2 receptor antagonist
| Target | Action | Gene / class |
| D(2) dopamine receptor efficacy |
ANTAGONIST |
DRD2 |
| D(3) dopamine receptor efficacy |
ANTAGONIST |
DRD3 |
Indications
Off-label
- Anxiety
- Dementia
- Depressive Disorder
- Psychotic Disorders
- Schizophrenia
- Tic Disorders
- Tourette Syndrome
Chemistry & Properties
| Formula | C15H24N2O4S |
| Molecular weight | 328.43 g/mol |
| IUPAC name | N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide |
| CAS | 51012-32-9 |
| PubChem CID | 5467 |
| InChIKey | JTVPZMFULRWINT-UHFFFAOYSA-N |
| logP | 1.17 (XLogP 0.9) |
| Polar surface area | 75.71 Ų |
| H-bond acceptors / donors | 5 / 1 |
| Drug-likeness (QED) | 0.78 |
| Lipinski violations | 0 |
SMILES
CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC
Biology & Pharmacokinetics
Pharmacokinetics
Enzyme interactions
| Enzyme | Role | Detail |
| CYP2C19 | Substrate |
— |
Receptor binding (top 3)
| Target | Action | Affinity |
| DOPAMINE D4 (DRD4) |
Binding |
pKi 7.9 |
| DOPAMINE D2 (DRD2) |
Binding |
pKi 7.1 |
| DOPAMINE D3 (DRD3) |
Binding |
pKi 6.8 |
Transporters
BCRP (Inhibitor)BSEP (Inhibitor)BSEP (Inhibitor)MRP1 (Inhibitor)MRP2 (Inhibitor)MRP3 (Inhibitor)MRP4 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)P-gp (Inhibitor)P-gp (Substrate)
Registered Products (2)
| Brand | Form / strength | Pack | Agent | Citizen (JOD) |
| TIAPRIDAL TAB
|
Tablet 100 mg |
20 tab |
Ulfa Pharma Co. |
2.020 |
| TIAPRIDAL AMP
|
Ampoule 100 mg |
12 amp |
Ulfa Pharma Co. |
2.830 |